Basic Information
| RNALocate ID: | RLID:11002910 |
| RNA Symbol: | hsa-miR-410-3p |
| Localization: | Microvesicle |
RNA Information
| RNA Name: | hsa-miR-410 |
| RNA ID: | miRBase:MIMAT0002171 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23666971 |
| Tissue/Cell Line: | Follicular fluid |
| Method: | Microarray |
| Description: | The TaqMan miRNA Array Card version 3.0, which includes 766 mature miRNAs, detected the presence of miRNAs in both the microvesicles and the supernatant. A total of 120 miRNAs (cycle threshold [Ct] <37) were found in the in microvesicles extracted from 8 mL fresh follicular fluid, and 82 miRNAs (Ct <37) were expressed in 500 uL supernatant (Table 2). Data are collected from Table 2. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002303 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:11002905 | Exosome | Serum | 18589210 |
| RLID:11002906 | Exosome | Brain tissue | 23382797 |
| RLID:11002907 | Exosome | Plasma | 23663360 |
| RLID:11002908 | Exosome | Plasma | 24683445 |
| RLID:11002909 | Exosome | B cell lymphoma cell lines|EBV-transformed lymphoblastoid B cells | 25242326 |
| RLID-D:11000147 | Exosome | Blood|Endothelial cells | |
| RLID-D:11000467 | Microvesicle | Blood|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-410-3p | Oral squamous cell carcinoma | MNDR-E-MI-48000 |
| MNDR | hsa-miR-410-3p | Medulloblastoma | MNDR-E-MI-48001 |
| MNDR | hsa-miR-410-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-48002 |
| MNDR | hsa-miR-410-3p | Lymphoma | MNDR-E-MI-48003 |
| MNDR | hsa-miR-410-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-48004 |
| MNDR | hsa-miR-410-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-48005 |
| MNDR | hsa-miR-410-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-48006 |
| MNDR | hsa-miR-410-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-48007 |
| MNDR | hsa-miR-410-3p | Her2-receptor positive breast cancer | MNDR-E-MI-48008 |
| MNDR | hsa-miR-410-3p | Prostate cancer | MNDR-E-MI-48009 |
| MNDR | hsa-miR-410-3p | Gastric cancer | MNDR-E-MI-48010 |
| MNDR | hsa-miR-410-3p | Alzheimer disease | MNDR-E-MI-48011 |
| MNDR | hsa-miR-410-3p | Dysautonomia familial | MNDR-E-MI-48012 |
| MNDR | hsa-miR-410-3p | Myotonic dystrophy | MNDR-E-MI-48013 |
| MNDR | hsa-miR-410-3p | Head and neck cancer | MNDR-E-MI-48014 |
| MNDR | hsa-miR-410-3p | Endometrial cancer | MNDR-E-MI-48015 |
| MNDR | hsa-miR-410-3p | Down syndrome | MNDR-E-MI-48016 |
| MNDR | hsa-miR-410-3p | Parkinson disease | MNDR-E-MI-48017 |
| MNDR | hsa-miR-410-3p | Breast cancer | MNDR-E-MI-48018 |
| MNDR | hsa-miR-410-3p | Thyroid cancer | MNDR-E-MI-48019 |
| MNDR | hsa-miR-410-3p | Pituitary neoplasms | MNDR-E-MI-48020 |
| MNDR | hsa-miR-410-3p | Pancreatic cancer | MNDR-E-MI-48021 |
| MNDR | hsa-miR-410-3p | Melanoma | MNDR-E-MI-48022 |
| MNDR | hsa-miR-410-3p | Nephroblastoma | MNDR-E-MI-48023 |
| MNDR | hsa-miR-410-3p | Colon cancer | MNDR-E-MI-48024 |
| MNDR | hsa-miR-410-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-48025 |
| MNDR | hsa-miR-410-3p | Familial ovarian cancer | MNDR-E-MI-48026 |
| MNDR | hsa-miR-410-3p | Prostate adenocarcinoma | MNDR-E-MI-48027 |
| MNDR | hsa-miR-410-3p | Carcinoma ductal breast | MNDR-E-MI-48028 |
| MNDR | hsa-miR-410-3p | Glioblastoma | MNDR-E-MI-48029 |
| MNDR | hsa-miR-410-3p | Glioma | MNDR-E-MI-48030 |
| MNDR | hsa-miR-410-3p | Meningioma | MNDR-E-MI-48031 |
| MNDR | hsa-miR-410-3p | Liver neoplasms | MNDR-E-MI-48032 |
| MNDR | hsa-miR-410-3p | Gastric adenocarcinoma | MNDR-E-MI-48033 |
| MNDR | hsa-miR-410-3p | Cervical squamous cell carcinoma | MNDR-E-MI-48034 |
| MNDR | hsa-miR-410-3p | Bone-invasive pituitary adenoma | MNDR-E-MI-48035 |
| MNDR | hsa-miR-410-3p | Lung squamous cell carcinoma | MNDR-E-MI-48036 |
| MNDR | hsa-miR-410-3p | Lung adenocarcinoma | MNDR-E-MI-48037 |
| MNDR | hsa-miR-410-3p | Adrenocortical cancer | MNDR-E-MI-48038 |
| MNDR | hsa-miR-410-3p | Thyroid carcinoma | MNDR-E-MI-48039 |
| MNDR | hsa-miR-410-3p | Bladder urothelial carcinoma | MNDR-E-MI-48040 |
| MNDR | hsa-miR-410-3p | Pancreatic adenocarcinoma | MNDR-E-MI-48041 |
| MNDR | hsa-miR-410-3p | Carcinoma renal cell | MNDR-E-MI-48042 |
| MNDR | hsa-miR-410-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-48043 |
| MNDR | hsa-miR-410-3p | Esophageal cancer | MNDR-E-MI-48044 |
| MNDR | hsa-miR-410-3p | Lung small cell carcinoma | MNDR-E-MI-48045 |
| MNDR | hsa-miR-410-3p | Synovial sarcoma | MNDR-E-MI-48046 |
| MNDR | hsa-miR-410-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-48047 |
| MNDR | hsa-miR-410-3p | Breast invasive carcinoma | MNDR-E-MI-48048 |
| MNDR | hsa-miR-410-3p | Hepatocellular carcinoma | MNDR-E-MI-48049 |
| MNDR | hsa-miR-410-3p | Familiar ovarian carcinoma | MNDR-E-MI-48050 |
| MNDR | hsa-miR-410-3p | Rheumatoid arthritis | MNDR-E-MI-48051 |
| MNDR | hsa-miR-410-3p | Burkitt lymphoma | MNDR-E-MI-48052 |
| MNDR | hsa-miR-410-3p | Tonsil cancer | MNDR-E-MI-48053 |
| MNDR | hsa-miR-410-3p | Neuromyelitis optica | MNDR-E-MI-48054 |
| MNDR | hsa-miR-410-3p | Colorectal cancer | MNDR-E-MI-48055 |
| MNDR | hsa-miR-410-3p | Aids dementia complex | MNDR-E-MI-48056 |
| MNDR | hsa-miR-410-3p | Breast cancer her3+ negative | MNDR-E-MI-48057 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | AGTR1 | Homo sapiens | RR00057153 |
TOP